Logo

Massive Bio: Özgür Huner, Erkan Terzi, Gretchen O'Neill, David Henka

Dec 16, 2022

Massive Bio, a New York City-based company using AI and molecular biology tools for cancer clinical trial matching, this week announced new C-Suite hires and executive director appointments.

Massive Bio appointed Özgür "Oz" Huner as its first chief product officer. Huner previously served as molecular products lead at Verily Life Sciences. He also has held roles in the areas of oncology and genomics for companies including Sema4, Qiagen, Genomic Health, Lifelabs, NexJ, and Deloitte.

The company also said that it promoted Erkan Terzi to the role of chief marketing officer. Erkan has developed and managed marketing programs for brands such as Allianz, Comcast Spotlight, LG Electronics, and Aselsan.

In addition, Gretchen O' Neill has joined Massive Bio as executive director of clinical operations, while David Henka has joined the company as director of global strategic partnerships.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.